A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis.

Source:http://linkedlifedata.com/resource/pubmed/id/11464953

Download in:

View as

General Info

PMID
11464953